Drug Trial Radar · NCT06851559
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
95
Actual
Start
Oct 30, 2025
Primary completion
Sep 11, 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Phathom Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess the efficacy of vonoprazan 20 mg once daily (QD) compared to placebo QD in the number of participants with a peak eosinophilic histologic response \<15 eosinophils per high-power field (eos/hpf) after 12 weeks of therapy.
Conditions
- Eosinophilic Esophagitis
Interventions
VonoprazanDrug
Vonoprazan will be administered orally as a tablet
PlaceboDrug
Placebo will be administered orally as tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants at Week 12 Achieving Peak Esophageal Intraepithelial Eosinophil Count <15 eos/hpf.Time frame: Week 12
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
Preferred Research Partners, Inc
Little Rock, Arkansas
GW Research, Inc
Chula Vista, California
Southern California Research Institute Medical Group
Los Angeles, California
Rocky Mountain Gastroenterology
Lakewood, Colorado
Western States Clinical Research, Inc.
Wheat Ridge, Colorado
Connecticut Clinical Research Institute
Bristol, Connecticut
Nature Coast Clinical Research
Inverness, Florida
Encore Borland-Groover Clinical Research
Jacksonville, Florida
International Center for Research
Tampa, Florida
Gastroenterology Associates of Central Georgia, LLC
Macon, Georgia
Treasure Valley Medical Research
Boise, Idaho
Grand Teton Research Group
Idaho Falls, Idaho
Northwestern Medicine Digestive Health Center
Chicago, Illinois
GI Alliance - Gurnee
Gurnee, Illinois
Combined Gastro, LLC
Lafayette, Louisiana
Tandem Clinical Research GI, LLC
Marrero, Louisiana
Woodholme Gastroenterology Associates
Glen Burnie, Maryland
Boston Specialists
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
Huron Gastroenterology Associates
Ypsilanti, Michigan
Advanced Research Institute
Reno, Nevada
Weill Cornell Medicine, New York Presbyterian Hospital
New York, New York
UNC Clinical & Translational Research Center
Chapel Hill, North Carolina
GCGA Physicians, LLC dba/Gastro Health Research
Cincinnati, Ohio
Great Lakes Gastroenterology Research LLC
Mentor, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
Galen Medical Group - Galen Digestive Health
Chattanooga, Tennessee
Quality Medical Research
Nashville, Tennessee
GI Alliance
Cedar Park, Texas
The Hospitals of Providence Memorial Campus
El Paso, Texas
Texas Digestive Specialists
Harlingen, Texas
Houston Endoscopy and Research Center
Houston, Texas
Research Physicians Network, LLC
Houston, Texas
Biopharma Informatic, LLC
McAllen, Texas
Pearland Physicians
Pearland, Texas
Gastroenterology Research of San Antonio
San Antonio, Texas
Texas Gastro Consultants
Tomball, Texas
Care Access - Ogdon
Ogden, Utah
Advanced Research Institute
Ogden, Utah
Advanced Research Institute
Sandy City, Utah
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.